Valuation : Astal Laboratories Limited

Market Cap 275.92Cr 2.92Cr 2.51Cr 2.37Cr 2.16Cr 4.04Cr 4.05Cr 28Cr 11Cr 141.57Cr 11Cr 11Cr 456.06Cr P/E 2024
26.3x
P/E 2025 9.45x
Enterprise Value 287.46Cr 3.04Cr 2.62Cr 2.46Cr 2.25Cr 4.21Cr 4.22Cr 29Cr 11Cr 147.49Cr 11Cr 11Cr 475.13Cr EV / Sales 2024
1.45x
EV / Sales 2025 1.36x
Free-Float
41.06%
Yield 2024 *
-
Yield 2025 -
1 day-3.20%
1 week-2.34%
Current month-4.32%
1 month-7.32%
3 months+12.99%
6 months+8.39%
Current year-11.46%
1 week 74.05
Extreme 74.05
81
1 month 74.05
Extreme 74.05
89.5
Current year 60.45
Extreme 60.45
91.9
1 year 60.45
Extreme 60.45
103.2
3 years 32.05
Extreme 32.05
131.7
5 years 5.41
Extreme 5.41
131.7
10 years 5.41
Extreme 5.41
131.7
Manager TitleAgeSince
Director of Finance/CFO 51 15/07/2023
Compliance Officer 32 19/04/2023
Director TitleAgeSince
Director/Board Member - 08/09/2022
Director/Board Member - 08/09/2022
Director/Board Member - 08/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
-3.20%-2.34%-7.88%+139.94% 3.68Cr
-0.88%-2.15%+54.71%+106.31% 1,03400Cr
-1.15%+2.68%+53.97%+71.50% 67TCr
-1.44%+0.38%+20.40%+73.05% 46TCr
+0.14%-0.47%+29.49%+38.56% 35TCr
-1.33%+4.72%+24.69%+45.55% 31TCr
-1.15%+0.30%-1.49%+12.31% 26TCr
-1.55%+1.11%+56.10%+70.32% 24TCr
-0.88%+1.15%-17.09%-54.39% 21TCr
-0.15%+3.65%+33.90%+96.99% 19TCr
Average -1.21%+0.84%+24.68%+60.01% 37.17TCr
Weighted average by Cap. -1.10%+0.51%+36.61%+66.21%

Financials

2024 2025
Net sales 24Cr 25.06L 21.56L 20.29L 18.53L 34.67L 34.77L 2.4Cr 93.03L 12Cr 94.1L 92.05L 39Cr 64Cr 67.42L 58.02L 54.58L 49.86L 93.28L 93.53L 6.45Cr 2.5Cr 33Cr 2.53Cr 2.48Cr 105.21Cr
Net income 78.47L 83.11T 71.52T 67.29T 61.47T 1L 1L 8L 3L 40.26L 3L 3L 1.3Cr 8.93Cr 9L 8L 8L 7L 13.08L 13.11L 90.44L 35.09L 4.58Cr 35.5L 34.72L 15Cr
Net Debt -5.76Cr -6L -5L -5L -5L -8L -8L -58.41L -22.67L -2.96Cr -22.93L -22.43L -9.53Cr 12Cr 12.22L 10.52L 10L 9L 16.91L 16.95L 1.17Cr 45.37L 5.92Cr 45.89L 44.89L 19Cr
Logo Astal Laboratories Limited
Astal Laboratories Limited is an India-based company, which is engaged in the manufacturing and sale of pharmaceutical intermediates and bulk drugs. The Company is engaged in manufacturing fine chemicals, specialty chemicals and pharmaceutical intermediates. The Company’s products include HF Acid (2-Chloro-1,3-Bis (Dimethylamino) Trimethinium Hexafluorophosphate); 4-Methyl Sulphonyl Phenyl Acetic acid, (1R,3R)-methyl 1-(benzo[d][1,3] dioxol-5-yl)- 2,3,4,9-tetrahydro-1 H-pyrido[3,4-b]indole-3- carboxylate hydrochloride; L-Valine methyl ester Hydrochloride (LVMH); L-Valine benzyl ester Hydrochloride; N-[(2-Cyanobiphenyl-4-methyl)- L-Valine methyl ester Hydrochloride; D-Tryptophan Methyl Ester Hydrochloride; Moc-L-valine (N-(Methoxycarbonyl)-L-valine); 2-Ethoxyethyl-4-methylbenzene sulfonate; 2 Piperidin-4-yl-1H-benzoimidazole; Alpha, alpha-Dimethyl Phenyl Acetic Acid (2-Methyl-2-phenylpropionic acid); 2-(4-bromophenyl)-2-methylpropionic acid; Methyl 2,2-dimethylphenylacetate, and others.
Employees
-
Date Price Change Volume
04/26/04 ₹76.90 -3.20% 33,026
03/26/03 ₹79.44 +1.37% 39,069
02/26/02 ₹78.37 +0.62% 22,998
01/26/01 ₹77.89 -3.09% 21,825
31/26/31 ₹80.37 +2.07% 13,076
  1. Stock Market
  2. Stocks
  3. MACINTR Stock